搜索临床试验以:阿托伐他汀(立普妥)
总计983个结果
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University暂停
-
Takeda完全的血脂异常美国, 德国, 阿根廷, 墨西哥, 波兰, 南非, 智利, 荷兰, 秘鲁, 爱沙尼亚, 俄罗斯联邦, 捷克共和国, 匈牙利, 立陶宛, 拉脱维亚, 斯洛伐克, 英国
-
Organon and Co完全的
-
Cedars-Sinai Medical CenterCalifornia Breast Cancer Research Program终止
-
University of Oxford完全的
-
Dean FelsherThe Leukemia and Lymphoma Society; Burroughs Wellcome; Damon Runyon Cancer Research Foundation完全的
-
National Taiwan University HospitalNational Science Council, Taiwan未知
-
Mansoura University主动,不招人
-
Organon and CoMerck Sharp & Dohme LLC终止冠状动脉疾病 | 动脉粥样硬化 | 高胆固醇血症
-
Hospital for Special Surgery, New YorkWashington University School of Medicine; Weill Medical College of Cornell University; University...完全的
-
University of RochesterPfizer完全的
-
Prof. Stephen LeePfizer; Queen Mary Hospital, Hong Kong完全的
-
University of California, San DiegoUniversity of Colorado, Denver; Children's Hospital Colorado完全的
-
University of PennsylvaniaNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Queen's UniversityThe Physicians' Services Incorporated Foundation; Ontario Lung Association终止
-
St Vincent's University Hospital, IrelandUniversity College Dublin; University College Cork; University of Dublin, Trinity College完全的
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Monash UniversityNational Health and Medical Research Council, Australia; National Heart Foundation, Australia主动,不招人
-
Keimyung University Dongsan Medical CenterSeoul National University Hospital; Ulsan University Hospital; Inje University Ilsan Paik Hospital完全的
-
University of FloridaAmerican Heart Association; American College of Clinical Pharmacy完全的
-
UMC Utrecht完全的高血压 | Stable Chronic Kidney Disease荷兰
-
Beth Israel Deaconess Medical CenterNational Institute of General Medical Sciences (NIGMS)完全的
-
Hartford HospitalNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)完全的
-
University of TorontoPfizer; Unity Health Toronto; Canadian Heart Research Centre; Ontario Association of Optometrists; Toronto Ophthalmological Society未知
-
Zhujiang Hospital尚未招聘疗效终点:1年内无新的脑血管不良事件 | 安全终点:一年内没有新的中度或严重不良事件 | 全因死亡事件(一年内) | 缺血性中风事件(1年内) | 新的出血性中风事件(1年内) | 新支架血栓事件(1年内) | 新的症状性狭窄事件(1 年内) | 支架内狭窄的发生 第 12 ±1 个月年度血管造影随访 | 第 12 ±1 个月年度血管造影随访时的支架内狭窄程度(采用 WASID 方法测量) | 每年 12±1 个月血管造影随访时的目标动脉瘤栓塞率(Raymond 和 OKM 分类)